Inotek Corporation

Download PDF
Email profile changes
Upgrade this profile
Add a new company

Members:
Ammend this profile
Login

Free radical and oxidant-mediated diseases.

Contact Details: Beverly MA United States of America Tel: Fax: Email:

Recent Publications by Inotek Corporation:
Facile and convenient syntheses of 6,11-dihydro-5H-indeno[1,2-c]isoquinolin- 5-ones and 6,11-dihydro-5H-indolo[3,2-c]isoquinolin-5-one. [reaction: see text] The synthesis of...	10th February, 2006	Inotek Pharmaceuticals Corporation, 100 Cummings Center, Beverly,	Org Lett. 2005 Apr 28;7(9):1753-6. DOI Direct Link
Mechanisms of cell necrosis. Amiloride-sensitive, epithelial Na(+) channel (ENaC)-mediated, active...	19th January, 2006	Inotek Pharmaceuticals Corporation, Beverly, MA, USA.	Crit Care Med. 2005 Dec;33(12 Suppl):S530-4.
Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation. Activation of poly(ADP-ribose) polymerase (PARP) is an important factor in...	13th January, 2006	Inotek Pharmaceuticals Corporation, Beverly, Massachusetts, USA.	J Pharmacol Exp Ther. 2005 Nov;315(2):812-20. Epub 2005 Aug 3. DOI Direct Link
Cytokines stimulate expression of inducible nitric oxide synthase in DLD-1 human adenocarcinoma cells by activating poly(A) polymerase. OBJECTIVE: The stimulation of epithelial cells by cytokines or...	3rd November, 2005	Inotek Pharmaceuticals Corporation, 100 Cummings Center, Suite 419E,	Inflamm Res. 2004 Nov;53(11):604-8.
Angiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation. Angiotensin II (AII) contributes to the pathogenesis of many...	20th October, 2005	Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center,	Mol Med. 2004 Jan-Jun;10(1-6):28-35.
→View more Inotek Corporation research publications.

BioNews Results for Inotek Corporation:
Inotek Appoints Paul G. Howes as President and CEO	Pharma Live:  Oct 3 2008 8:44AM Matching: inotek
Inotek Pharmaceuticals names new president and CEO	Pharmaceutical Business Review:  Oct 3 2008 9:06AM Matching: inotek
Inotek Appoints Paul G. Howes as President and CEO	Healthcare Sales & Marketing Network:  Oct 2 2008 10:49AM Matching: inotek
Inotek Appoints Paul G. Howes as President and CEO	PR inside:  Oct 1 2008 7:27PM Matching: inotek
Inotek Appoints Paul G. Howes as President and CEO	Calibre Macro World:  Oct 1 2008 2:13PM Matching: inotek
Promote your company here: BioNewsCast - Press Release Distribution	→View more Inotek Corporation news.

Inotek Corporation Patents:
US Patent No.	Title
7423144	Purine Derivatives as adenosine A.sub.1 receptor agonists and methods of use thereof
6534651	7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
6531464	Methods for the treatment of neurodegenerative disorders using substituted phenanthridinone derivatives
6476048	Substituted phenanthridinones and methods of use thereof
6281222	Compositions and method for treatment of acetaminophen intoxication
→View more Inotek Corporation patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 20 individuals from Inotek Corporation using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 164 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: inotek Apr 14 | inotek genentech 2008 | inotek corporation | Inotek | .

Search for more companies in Beverly

Search for more companies in MA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Inotek Corporation

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.